This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Disease Info Card
Tonic Convulsion
Information about Tonic Convulsion: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Tonic Convulsion
Most recent studies have shown that Tonic Convulsion shares some biological mechanisms with absence-epilepsy, clonic-convulsion, convulsions, convulsive-seizures, encephalopathies, epilepsies-myoclonic, epilepsies-partial, epilepsy, epilepsy-generalized, generalized-seizures, infantile-spasms, kindling-neurologic, lennox-gastaut-syndrome, partial-seizure, sclerosis, spasm, status-epilepticus, tonic-clonic-epilepsy.
Among the many pathways, these few ones have gauged particular interests from scientists studying Tonic Convulsion, and have been seen in publications frequently: Cell Activation, Cell Death, Coagulation, Cognition, Developmental Process, Excretion, Habituation, Localization, Locomotion, Mating, Muscle Contraction, Myelination, Pathogenesis, Reflex, Righting Reflex, Secretion, Sensitization, Startle Response, Swimming, Transport
Quite a number of genes have been found to play important roles in Tonic Convulsion, such as AURKA, BDNF, CA1, CA3, CDKL5, CSF2, FMN1, FOS, FOXC2, ICAM3, LAMC2, MBP, ME1, MKS1, NOS1, NOS2, NPY, POMC. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.